P198 Prognostic value of breast cancer subtypes: from phase 2 randomized trial of neoadjuvant therapy von Semiglazov, V.F, Dashyan, G.A, Semiglazov, V.V, Petrenko, O, Komyahov, A, Paltuev, R.M, Matzko, D

Volltext

426 Neoadjuvant Endocrine Therapy: Retrospective Analysis of Some Mechanisms of Resistance von Semiglazov, V.F, Manikhas, A.G, Semiglazov, V.V, Dashyan, G.A, Ivanov, V.G, Paltuev, R.M, Zhiltsova, E.K, Bozhok, A.A, Skvortsov, V.V, Raskin, G.G

Volltext

248. Breast recurrence after conservative surgery in patient with minimal (pT1a-bN0M0) breast cancer (significance of molecular subtype) von Semiglazov, V.F, Paltuev, R.M, Bozhok, A.A, Semiglazov, V.V, Zernov, K.U, Krivorotko, P.V, Grechukhina, I.A, Ermachenkova, A.M, Penkov, K.D

Volltext

P181 Factors influencing prognosis in node-negative early breast cancer (p)T1N0M0 von Semiglazov, V.F, Paltuev, R.M, Nikitina, I.V, Semiglazov, V.V, Dashyan, G.A, Bozjok, A.A, Manikhas, A.G, Bessonov, A.A, Vasiliev, A.G, Penkov, K.D

Volltext

0177 Primary endocrine therapy versus chemotherapy in postmenopausal patients with ER-positive breast cancer: 5-year results von Semiglazov, V.F, Dashyan, G.A, Semiglazov, V.V, Ziltsova, E.K, Malodusheva, A.A, Ivanov, V.G, Donskih, R.V, Bozhok, A.A, Paltuev, R.M, Berstein, L.M

Volltext

9 Breast-conserving surgery after preoperative endocrine therapy versus chemotherapy in postmenopausal patients with estrogen-receptor-positive breast cancer von Semiglazov, V.F, Semiglazov, V.V, Dashyan, G.A, Manikhas, A.G, Ziltsova, E.K, Malodusheva, A.A, Ivanov, V.G, Donskih, R.V, Paltuev, R.M, Kletsel, A.E

Volltext

P131 The neoadjuvant endocrinetherapy vs chemotherapy in postmenopausal woment with ER-positive breast cancer von Semiglazov, V.F, Semiglazov, V.V, Ivanov, V.G, Zhiltzova, E.R, Kletsel, A.E, Dashyan, G.A, Bozhok, A.A, Paltuev, R.M, Berstein, L.M, Krivorotko, P.V

Volltext

New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer von Semiglazova, T.Yu, Klyuge, V.A, Semiglazov, V.V., Teletaeva, G.M., Krivorotko, P.V., Dashyan, G.A., Paltuev, R.M., Tkachenko, E.V., Donskikh, R.V, Semiglazov, V.F.

Volltext

Neoadjuvant chemotherapy paclitaxel + doxorubicin (PD) vs fluorouracil + doxorubicin + cyclophosphamide (FAC) in locally advanced breast cancer: Clinical and pathological response von Semiglazov, V.F., Bojok, A.A., Arsumanov, A.S., Ivanova, O.A., Ivanov, V.G., Semiglazov, V.V., Pozharissky, K.M., Topuzov, E.E., Nurgaziev, K.S., Paltuev, R.M.

Volltext

Preoperative hormonal therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients von Semiglazov, V.F, Semiglazov, V.V, Ivanov, V.G, Ziltsova, E.K, Dashian, G.A, Kletzel, A, Bozhok, A.A, Topuzov, E.E, Paltuev, R.M, Berstein, L.M

Volltext

METHOD FOR COMPLEX EVALUATION OF TUMOR SENSITIVITY TO CHEMOTHERAPY AT MAMMARY GLAND CANCER von SEMIGLAZOV V.V, IVANOV V.G, NURGAZIEV KUANESH KASHTYBAEVICH, UPOROV A.V, SEMIGLAZOV V.F, TOPUZOV EH.EH, BOZHOK A.A, PALTUEV R.M

Volltext bestellen